Cytochrome P450 1A1 gene polymorphisms and endometrial cancer risk: A meta-analysis

International Journal of Gynecological Cancer

Volumn 21, Issue 2, 2011, Pages 323-331

  Sergentanis, Theodoros N ^a,b   Economopoulos, Konstantinos P ^a,b   Choussein, Souzana ^a,b   Vlahos, Nikos F ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Society of Junior Doctors   (Greece)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytochrome P450 1A1; Endometrial cancer; Ile462Val polymorphism; MspI polymorphism; Thr461Asn polymorphism

Indexed keywords

ASPARAGINE; CYTOCHROME P450 1A1; ISOLEUCINE; THREONINE; VALINE;

ARTICLE; CANCER RISK; CAUCASIAN; ENDOMETRIUM CANCER; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS (TOPIC); MSP1 GENE; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

CYTOCHROME P-450 CYP1A1; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; RISK;

EID: 79956150209     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31820575c0     Document Type: Article

References (25)

1. Androutsopoulos VP, Tsatsakis AM, Spandidos DA. Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer. 2009;9:187.
2. Spink DC, Eugster HP, Lincoln DW2nd, et al. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch Biochem Biophys. 1992;293:342-348.
3. Crofts F, Taioli E, Trachman J, et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis. 1994;15:2961-2963.
4. Shi X, Zhou S, Wang Z, et al. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer. 2008;59:155-163. (Pubitemid 351173406)
5. Zhuo WL, Zhang YS, Wang Y, et al. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses. Arch Med Res. 2009;40:169-179.
6. Sergentanis TN, Economopoulos KP. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122:459-469.
7. Economopoulos KP, Sergentanis TN. Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122:545Y551.
8. Economopoulos KP, Choussein S, Vlahos NF, et al. GSTM1, GSTT1 polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer. 2010;20:1576-1580.
9. Cavalli-Sforza LL, Piazza A, Menozzi P, et al. Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data. Proc Natl Acad Sci U S A. 1988;85:6002-6006.
10. Armitage P, Berry G. Statistical Methods in Medical Research. 3rd ed. Oxford, UK: Blackwell; 1994.
11. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 The Cochrane Collaboration, 2008 Available from: http://www.cochrane-handbook.org. Accessed: June 15, 2010.
12. Sergentanis TN, Economopoulos KP. GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;121:195-202.
13. Economopoulos KP, Sergentanis TN, Vlahos NF. GSTM1, GSTT1, GSTP1 polymorphisms and ovarian cancer risk: a meta-analysis. Int J Gynecol Cancer. 2010;20:732-737.
14. Ashton KA, Proietto A, Otton G, et al. Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk. Cancer Epidemiol. 2010;34:328-337.
15. Hirata H, Hinoda Y, Okayama N, et al. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer. 2008;112:1964-1973. (Pubitemid 351574072)
16. Gulyaeva LF, Mikhailova ON, PustyInyak VO, et al. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia. Adv Exp Med Biol. 2008;617:359-366.
17. McGrath M, Hankinson SE, De Vivo I. Cytochrome P450 1A1, cigarette smoking, and risk of endometrial cancer (United States). Cancer Causes Control. 2007;18:1123-1130. (Pubitemid 47498161)
18. Rebbeck TR, Troxel AB, Wang Y, et al. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. J Natl Cancer Inst. 2006;98:1311-1320. (Pubitemid 44530726)
19. Esinler I, Aktas D, Alikasifoglu M, et al. CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma. Int J Gynecol Cancer. 2006;16: 1407-1411. (Pubitemid 43886777)
20. Seremak-Mrozikiewicz A, Drews K, Semczuk A, et al. CYP1A1 alleles in female genital cancers in the Polish population. Eur J Obstet Gynecol Reprod Biol. 2005;118: 246-250. (Pubitemid 40093844)
21. Doherty JA, Weiss NS, Freeman RJ, et al. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:357-366. (Pubitemid 40270097)
22. Sugawara T, Nomura E, Sagawa T, et al. CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int J Gynecol Cancer. 2003;13:785-790. (Pubitemid 38235223)
23. Esteller M, Garcia A, Martinez-Palones JM, et al. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis. 1997;18:2307-2311. (Pubitemid 28134642)
24. Esteller M, Garcia A, Martinez-Palones JM, et al. Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci. Br J Cancer. 1997;75:1385-1388. (Pubitemid 27179834)
25. Ioannidis JP, Ntzani EE, Trikalinos TA, et al. Replication validity of genetic association studies. Nat Genet. 2001;29: 306-309.xs (Pubitemid 33096456)